Oncologica is a leading contract research organization specializing in small and large end-to-end bioinformatic CRO laboratory services. We offer bioanalytical clinical contract research to aid drug and targeted medicine innovation through our expertise in genetic cell-based assays, molecular biomarkers and immunogenicity services.
We work as a collaborative CRO partner to deliver integrated bioanalytical contract research solutions for your genomic sequencing needs. We excel in bioinformatics contract research where extensive sequencing capabilities and accurate detection of variants are required.
- Human genetics research partner
- Outsource genetic studies
- Bioanalytical pre-clinical contract research
- Drug manufacturing bioanalytical research
- UK based genetic CRO
Genomic Sequencing Services
Oncologica sequencing capabilities are suitable for:
- Rare disease studies
- Cancer exome analysis
- Complex disease genomics
- Translational research
RNA Sequencing Services
Our highly experienced bioinformatics team utilise lab sequencing and a leading genomic data library, for analysis and interpretation of:
- Gene expression
- Transcriptome analysis
- RNA sequencing services
Sequencing for the Microbiome
Our wide range sequencing capabilities allows our researchers to sequence all given genomic DNA in a complex sample. This provides valuable insights into community biodiversity and function. The sequencing data can be used for metagenomic assembly, function and gene resistance profiling.
Bacterial RNA Sequencing
Oncologica Sequencing provides bacterial RNA sequencing, which can identify and compare bacterial community in a sample by sequencing regions of the bacterial 16s rRNA gene.
- Access Oncologica’s large database of genomic data
- Undertake bioinformatic analysis for taxonomy assignment
DNA replication licensing, and survival are linked in prostate cancer
Br J Cancer. 2007 May 7;96(9):1384-93.
Dudderidge TJ, McCracken SR, Loddo M, Fanshawe TR, Kelly JD, Neal DE, Leung HY, Williams GH, Stoeber K.
Small-molecule mimics of an alpha-helix for efficient transport of proteins into cells
Nat Methods. 2007 Feb;4(2):153-9.
Okuyama M, Laman H, Kingsbury SR, Visintin C, Leo E, Eward KL, Stoeber K, Boshoff C, Williams GH, Selwood DL.
Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma
Liver Int. 2006 May;26(4):424-32.
Quaglia A, McStay M, Stoeber K, Loddo M, Caplin M, Fanshawe T, Williams G, Dhillon A.
DNA replication licensing and cell cycle kinetics of normal and neoplastic breast
Br J Cancer. 2005 Nov 28;93(11):1295-300.
Shetty A, Loddo M, Fanshawe T, Prevost AT, Sainsbury R, Williams GH, Stoeber K.
Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells
Exp Cell Res. 2005 Sep 10;309(1):56-67.
Kingsbury SR, Loddo M, Fanshawe T, Obermann EC, Prevost AT, Stoeber K, Williams GH.
DNA replication licensing in peripheral B-cell lymphoma
J Pathol. 2005 Feb;205(3):318-28.
Obermann EC, Eward KL, Dogan A, Paul EA, Loddo M, Munson P, Williams GH, Stoeber K.